Medical Cannabis

As the legal cannabis industry rapidly expands worldwide, the “green rush” is having a significant impact in Israel, which is emerging as a major player in this rapidly growing global market.

Shibolet is regarded as one of Israel’s first law firms to develop proven experience in advising clients on all aspects of cannabis business and regulation.

Today, our dedicated Cannabis Practice represents many industry players throughout the Israeli cannabis value chain, including propagation, cultivation, processing, and manufacturing companies.

In addition, our firm represents research institutions and technology companies engaged in various aspects of cannabis research, including agtech, medical device, and biopharma companies. We also represent both local and international specialized investors, such as angels and venture capital firms.

Our highly experienced attorneys hold the required legal, regulatory, and commercial expertise to supply our diverse clients with a broad spectrum of legal services, including general legal advice, corporate and financing work, and services relating to commercial transactions such as cross-border transactions, licensing, assistance complying with Israeli cannabis regulations, and other ancillary activities.

Related News


Medical Cannabis: Return to Investors & Horizon for decades to come, Adv. Adam Dozetas

Read More